Akari Therapeutics Balance Sheet
Akari Therapeutics's total assets for Q4 2025 were $47.89M, an increase of 5.54% from the previous quarter. AKTX total liabilities were $19.56M for the fiscal quarter, a -13.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.